David Rubin, MD, a nationally recognized authority on digestive disease, investigational therapies and medical ethics, has been named section chief of gastroenterology, hepatology and nutrition at the University of Chicago Medicine, effective May 1, 2014. He has served as interim chief since November, 2013.
Rubin, a professor of medicine at the University of Chicago, is co-director of the medical center’s Inflammatory Bowel Disease Center. He studies novel therapies for Crohn’s disease and ulcerative colitis, colon cancer prevention, and clinical medical ethics. He is the principal investigator for multiple clinical research projects and trials of novel therapies, including the first Food and Drug Administration-authorized study of fecal microbiota transplantation for ulcerative colitis.